SUSTAINABLE CRYSTALLINE MODIFICATIONS OF CHLORIDE DOTAP Russian patent published in 2017 - IPC C07C219/08 A61K47/18 A61K9/127 

Abstract RU 2627354 C2

FIELD: chemistry.

SUBSTANCE: invention relates to a method of manufacturing crystalline form of chloride (2R, S)-, (2S)- or (2R)-DOTAP (N, N, N-trimethyl-2,3-bis [[(9Z) -1-oxo -9-octadecenyl] oxy]-1-propanamide chloride). The process comprises crystallization chloride (2R, S)-, (2S)- or (2R)-DOTAP of one or more aprotic solvents, wherein the crystallisation takes place by cooling slowly from 35°C to -12°C for constituting 12 hours, or by slowly cooling from a temperature lower than the time period 35°. C over a period of time ranging from 10 to 50 parts crystalline chloride (2R, S)-DOTAP has one of the following characteristics: the values 2 theta, including at least the values constituting 12.6, 19.5, 20.2, 21.5 and 25.2; or 2 theta values, comprising at least the values of 6.5, 12.6, 13.4, 19.5, 20.2, 21.5, 25.2 and 29.8; or an X-ray powder diffraction, the diffraction pattern corresponding to FIG. 1. Crystalline chloride (2S)-DOTAP has one of the following characteristics: the values 2 theta, including at least the values constituting 12.8, 19.5, 19.8, 20.2 and 21.6; 2 theta values, comprising at least the values of 6.5, 12.8, 19.5, 19.8, 20.2, 20.7, 21.6 and 25.3; or an X-ray powder diffraction, the diffraction pattern corresponding to FIG. 2. Crystalline chloride (2S)-DOTAP has one of the following characteristics: the values 2 theta, including at least the values constituting 12.8, 19.5, 19.8, 20.2 and 21.6; 2 theta values, comprising at least the values of 6.5, 12.8, 19.5, 19.8, 20.2, 20.7, 21.6 and 25.3; or an X-ray powder diffraction, the diffraction pattern corresponding to FIG. 3. X-ray powder diffractometry was carried out using Cu as a radiation source.

EFFECT: proposed method allows to obtain crystalline forms of chloride with improved stability and purity.

8 cl, 12 dwg, 5 tbl, 5 ex

Similar patents RU2627354C2

Title Year Author Number
STABLE CRYSTALLINE CHLORIDE MODIFICATIONS DOTAP 2005
  • Placher Mikhaehl'
  • Khedinger Al'Fred
RU2463291C2
SOLID FORMS OF PLADIENOLIDE PYRIDINE COMPOUNDS AND METHODS FOR USE THEREOF 2016
  • Keaney, Gregg F.
  • Wang, John
  • Gerard, Baudouin
  • Arai, Kenzo
  • Liu, Xiang
  • Zheng, Guo Zhu
  • Kira, Kazunobu
  • Tivitmahaisoon, Parcharee
  • Prajapati, Sudeep
  • Gearhart, Nicholas C.
  • Kotake, Yoshihiko
  • Nagao, Satoshi
  • Kanada Sonabe, Regina Mikie
  • Miyano, Masayuki
  • Murai, Norio
  • Buonamici, Silvia
  • Yu, Lihua
  • Park, Eunice Sun
  • Chan, Betty
  • Smith, Peter G.
  • Thomas, Michael P.
  • Pazolli, Ermira
  • Lim, Kian Huat
  • Chanda, Arani
  • Endo, Atsushi
RU2743349C2
NOVEL CRYSTALLINE FORMS OF N-[-2[[(2,3-DIFLUOROPHENYL)METHYL]THIO]-6-{[(1R,2S)-2,3-DIHYDROXY-1-METHYLPROPYL]OXY}-4-PYRIMIDINYL]-1-AZATIDINE-SULPHONAMIDE 2011
  • Gullberg Britt Anne Ingela
  • Larsson Peter Thomas
  • Stonehouse Jeffrey Paul
RU2548044C2
SUBSTITUTED DERIVATIVES OF BISPHENYL ESTER OF BUTYRIC ACID AS NEP INHIBITORS 2019
  • Godtfredsen, Sven Erik
  • Kagan, Mark
  • Liu, Yugang
  • Prashad, Mahavir
  • Wang, Zhaoyin
  • Zhu, Saijie
  • Chai, Yongshuai
RU2784522C2
CHROMENONE COMPOUNDS AS PI3-KINASE INHIBITORS FOR TREATING CANCER 2012
  • Barlaam Bernard Christophe
  • Degorce Sebastien Louis
  • Lambert-Van Der Brempt Christine Marie Paul
  • Lohmann Jean-Jacques Marcel
  • Ple Patrick
RU2598028C2
METHOD FOR PREPARATION OF THE COMPOUND 2,2-DIFLUORO-N-((1R,2S)-3-FLUORO-1-HYDROXY-1-(4-(6-(S-METHYLSULFONIMIDOYL)PYRIDINE-3-YL)PHENYL)PROPANE-2-YL)ACETAMIDE 2019
  • Dejong Randall Lee
  • Karrick Gregory Lee
  • Stuk Timothy Lee
RU2765144C1
SALTS AND CRYSTALLINE FORMS 2014
  • Okumura Josiyuki
  • Ivata Yasukhiro
  • Numata Tojokharu
  • Sudo Masaki
  • Okumura Takako
RU2654855C2
CRYSTALLINE MODIFICATIONS OF HYDROCHLORIDE (-)-(1R, 2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)PHENOL 2005
  • Fisher Andreas
  • Bushmann Khel'Mut
  • Gruss Mikhaehl'
  • Lishke Dagmar
RU2423345C2
POLYMORPHIC AND PSEUDOPOLYMORPHIC FORMS OF PHARMACEUTICAL COMPOUND 2010
  • Bhattachrya Sisir
  • Bonnet Alain
  • Dedhiya Mahendra G.
  • Ducandas Veronigue
  • Giuliani Alexandre
  • Priour Alain
  • Ravaux Valerie
  • Spargo Peter
RU2575173C2
METHOD OF SYNTHESIS OF TRIAZOLES, ULTIMATE AND INTERMEDIATE COMPOUNDS OF METHOD 1996
  • Majkl Batters
  • Dzhuli Ehnn Kharrison
  • Alan Dzhon Pettman
RU2156760C2

RU 2 627 354 C2

Authors

Placher Mikhael Vilkhelm

Khedinger Alfred

Dates

2017-08-07Published

2012-05-02Filed